TLX is Telix Pharmaceuticals Limited (Healthcare) — a non-dividend-paying stock. Trading at $11.94. Market cap: $4.06B.
Stock snapshot
| Price | $11.94 |
| Market cap | $4.06B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About TLX
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Frequently asked
What is TLX's current stock price?
TLX (Telix Pharmaceuticals Limited) is currently trading at $11.94.
Does TLX pay a dividend?
TLX (Telix Pharmaceuticals Limited) does not currently pay a regular dividend.
Track TLX in DiviDrip
Add TLX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search TLX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.